1. Home
  2. LFMD vs TLSA Comparison

LFMD vs TLSA Comparison

Compare LFMD & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMD

LifeMD Inc.

HOLD

Current Price

$4.00

Market Cap

191.6M

Sector

Health Care

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.33

Market Cap

155.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFMD
TLSA
Founded
1994
2013
Country
United States
United Kingdom
Employees
336
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.6M
155.2M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
LFMD
TLSA
Price
$4.00
$1.33
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$9.14
N/A
AVG Volume (30 Days)
1.2M
111.1K
Earning Date
03-09-2026
05-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.76
N/A
Revenue Next Year
$17.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.60
$0.73
52 Week High
$15.34
$2.60

Technical Indicators

Market Signals
Indicator
LFMD
TLSA
Relative Strength Index (RSI) 59.34 47.74
Support Level $3.43 $1.28
Resistance Level $4.20 $1.56
Average True Range (ATR) 0.35 0.09
MACD 0.06 -0.00
Stochastic Oscillator 60.81 44.64

Price Performance

Historical Comparison
LFMD
TLSA

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.

Share on Social Networks: